The hopefulness surrounds Herbalife Ltd. (NYSE:HLF), as it aims to posts its Q1 results on Monday, April 29, 2013. Analysts are predicting the firm to record a profit of $1.07 per share, increased from 88 cents a year before.
Over the previous quarter, the consensus predicts has surged from $1.06. The analysts are predictions earnings of $4.67 a share for the fiscal year. Revenue is anticipated to be 16.2 percent above the year-earlier total of $964.2M at $1.12B for the quarter. The revenue is anticipated to come in at $4.62B for the year.
Over that span, the firm has averaged growth of 18 percent, with the largest increase coming in the Q1 of the previous fiscal year at what time revenue increased 21.3 percent from the year earlier quarter.
Herbalife Ltd. (NYSE:HLF) stock hit highest price at $38.41, beginning with a price of $38.29 and reported increased +0.92% to $38.30 at 10:16AM EDT with day range of $37.80-$38.41. The total market capitalization remained $3.95 billion current volume was 206,612.00 shares surprisingly higher than its average volume of 2.31 million shares.
To check the Stocks ups and downs, HLF last week stock price volatility remained 2.62% and month was at 3.50%. HLF generated revenue of 4.07 billion in the following twelve months income of $477.19 million. The Company showed a positive 11.72% in the net profit margin and in addition to in its operating margin which remained 16.24%. Company’s annual sales growth for the past five year was 13.67%.
The HLF past twelve months price to sales ratio was 0.96 and price to cash ratio remained 11.72. As far as if notice on other major contributors of similar sectors have sale ratio and price to cash ratio remained Prestige Brands Holdings, Inc. (NYSE:PBH)’s P/S 2.29% P/C 132.50%, Perrigo Company (NASDAQ:PRGO)’s P/S 3.43% P/C 24.34%, Lifevantage Corporation (NASDAQ:LFVN)’s P/S 1.36% P/C 8.94%, Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)’s P/S 2.03% P/C 5.10%.
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here